In a significant move within the pharmaceutical industry, a leading Indian drugmaker has expanded its diabetes care portfolio by acquiring a prominent insulin brand from Eli Lilly, a global healthcare company. This strategic acquisition, building upon an existing distribution partnership, aims to enhance access to essential insulin treatments for millions of diabetes patients across India. … Continue reading Pharma stock in green after acquiring Huminsulin drug from Eli Lilly to boost diabetes treatment